CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan HOOKIPA Pharma Inc. - HOOK CFD

0.9794
0.1%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0502
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.9784
Open* 0.9804
1-Year Change* -28.44%
Day's Range* 0.9784 - 1
52 wk Range 0.72-3.05
Average Volume (10 days) 201.04K
Average Volume (3 months) 6.63M
Market Cap 55.26M
P/E Ratio -100.00K
Shares Outstanding 54.72M
Revenue 10.32M
EPS -1.74
Dividend (Yield %) N/A
Beta 0.83
Next Earnings Date Mar 22, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 3, 2023 0.9794 -0.0010 -0.10% 0.9804 1.0097 0.9781
Feb 2, 2023 0.9784 0.0170 1.77% 0.9614 0.9902 0.9614
Feb 1, 2023 0.9615 -0.0063 -0.65% 0.9678 0.9804 0.9507
Jan 31, 2023 0.9705 0.0098 1.02% 0.9607 0.9804 0.9311
Jan 30, 2023 0.9509 -0.0028 -0.29% 0.9537 0.9706 0.9309
Jan 27, 2023 0.9804 0.0200 2.08% 0.9604 0.9804 0.9604
Jan 26, 2023 0.9606 0.0089 0.94% 0.9517 0.9804 0.9507
Jan 25, 2023 0.9607 0.0198 2.10% 0.9409 1.0000 0.9310
Jan 24, 2023 0.9431 -0.0274 -2.82% 0.9705 0.9707 0.9370
Jan 23, 2023 0.9626 -0.0273 -2.76% 0.9899 0.9902 0.9606
Jan 20, 2023 0.9804 0.0004 0.04% 0.9800 1.0000 0.9702
Jan 19, 2023 0.9902 0.0199 2.05% 0.9703 1.0098 0.9703
Jan 18, 2023 0.9803 -0.0193 -1.93% 0.9996 1.0392 0.9564
Jan 17, 2023 0.9998 0.0202 2.06% 0.9796 1.0196 0.9602
Jan 13, 2023 0.9706 0.0470 5.09% 0.9236 1.0000 0.9236
Jan 12, 2023 0.9412 0.0495 5.55% 0.8917 0.9607 0.8916
Jan 11, 2023 0.9313 0.0439 4.95% 0.8874 0.9510 0.8819
Jan 10, 2023 0.8921 0.0295 3.42% 0.8626 0.9018 0.8626
Jan 9, 2023 0.8708 -0.0308 -3.42% 0.9016 0.9216 0.8625
Jan 6, 2023 0.8626 0.0443 5.41% 0.8183 0.8848 0.8153

HOOKIPA Pharma Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2017 2018 2019 2020 2021
Total revenue 0 7.629 11.942 19.584 18.448
Revenue 0 7.629 11.942 19.584 18.448
Total Operating Expense 14.157 28.809 63.027 72.869 100.122
Selling/General/Admin. Expenses, Total 4.385 6.844 17.809 19.715 19.172
Research & Development 9.772 21.965 44.854 52.738 80.518
Operating Income -14.157 -21.18 -51.085 -53.285 -81.674
Interest Income (Expense), Net Non-Operating -0.606 -0.778 0.71 -0.386 -0.871
Other, Net 2.044 5.745 7.338 9.589 6.881
Net Income Before Taxes -12.719 -16.213 -43.037 -44.082 -75.664
Net Income After Taxes -12.723 -16.237 -43.037 -44.082 -75.665
Net Income Before Extra. Items -12.723 -16.237 -43.037 -44.082 -75.665
Net Income -12.723 -16.237 -43.037 -44.082 -75.665
Income Available to Common Excl. Extra. Items -12.723 -16.237 -43.037 -44.082 -75.665
Income Available to Common Incl. Extra. Items -12.723 -16.237 -43.037 -44.082 -75.665
Diluted Net Income -12.723 -16.237 -43.037 -44.082 -75.665
Diluted Weighted Average Shares 25.4085 25.4085 17.8599 26.0391 32.8336
Diluted EPS Excluding Extraordinary Items -0.50074 -0.63904 -2.4097 -1.69292 -2.3045
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.50074 -0.63904 -2.4097 -1.69292 -2.3045
Depreciation / Amortization 0.364 0.416 0.432
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 5.301 5.378 3.874 3.895 1.445
Revenue 5.301 5.378 3.874 3.895 1.445
Total Operating Expense 24.473 24.667 25.04 25.942 21.592
Selling/General/Admin. Expenses, Total 4.309 5.095 4.342 3.523 4.972
Research & Development 20.164 19.572 20.698 22.419 16.62
Operating Income -19.172 -19.289 -21.166 -22.047 -20.147
Interest Income (Expense), Net Non-Operating -0.212 -0.211 -0.227 -0.221 -0.236
Other, Net 2.146 2.347 1.354 1.033 2.415
Net Income Before Taxes -17.238 -17.153 -20.039 -21.235 -17.968
Net Income After Taxes -17.238 -17.153 -20.04 -21.235 -17.968
Net Income Before Extra. Items -17.238 -17.153 -20.04 -21.235 -17.968
Net Income -17.238 -17.153 -20.04 -21.235 -17.968
Income Available to Common Excl. Extra. Items -17.238 -17.153 -20.04 -21.235 -17.968
Income Available to Common Incl. Extra. Items -17.238 -17.153 -20.04 -21.235 -17.968
Diluted Net Income -17.238 -17.153 -20.04 -21.235 -17.968
Diluted Weighted Average Shares 29.7883 32.8043 32.8744 32.8882 38.603
Diluted EPS Excluding Extraordinary Items -0.57868 -0.52289 -0.60959 -0.64567 -0.46546
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.57868 -0.52289 -0.60959 -0.64567 -0.46546
  • Annual
  • Quarterly
2017 2018 2019 2020 2021
Total Current Assets 69.958 62.311 128.017 171.504 102.135
Cash and Short Term Investments 61.362 48.58 113.151 142.743 65.921
Cash & Equivalents 61.362 48.58 113.151 142.743 65.921
Total Receivables, Net 6.52 4.919 9.727 20.657 21.166
Accounts Receivable - Trade, Net 0 4.919 1.537 5.542 6.895
Prepaid Expenses 2.076 8.812 5.139 8.104 14.482
Total Assets 73.732 68.251 143.745 187.817 126.045
Property/Plant/Equipment, Total - Net 3.575 4.337 14.603 13.969 22.115
Property/Plant/Equipment, Total - Gross 5.116 6.403 18.049 19.066 28.481
Accumulated Depreciation, Total -1.541 -2.066 -3.446 -5.097 -6.366
Other Long Term Assets, Total 0.199 1.603 1.125 2.344 1.795
Total Current Liabilities 4.035 14.695 14.755 21.143 27.654
Accounts Payable 1.477 3.656 0.944 8.009 8.762
Accrued Expenses 2.558 4.42 5.262 7.138 9.598
Notes Payable/Short Term Debt 0 0 1.224 0 0
Other Current Liabilities, Total 0 6.619 7.166 5.841 6.481
Total Liabilities 11.614 23.852 25.846 31.694 36.453
Total Long Term Debt 3.738 4.392 3.862 4.795 2.219
Long Term Debt 3.738 4.392 3.495 4.537 2.219
Other Liabilities, Total 3.841 4.765 7.229 5.756 6.58
Total Equity 62.118 44.399 117.899 156.123 89.592
Redeemable Preferred Stock 104.774 104.774 0
Common Stock 0 0 0.003 0.003 0.003
Additional Paid-In Capital 2.451 3.327 225.568 309.288 317.135
Retained Earnings (Accumulated Deficit) -43.745 -59.982 -103.019 -147.101 -222.766
Other Equity, Total -1.362 -3.72 -4.653 -6.067 -4.78
Total Liabilities & Shareholders’ Equity 73.732 68.251 143.745 187.817 126.045
Total Common Shares Outstanding 25.4085 25.4085 25.5661 29.7684 31.2032
Current Port. of LT Debt/Capital Leases 0.159 0.155 2.813
Capital Lease Obligations 0.367 0.258 0
Preferred Stock - Non Redeemable, Net 0
Other Current Assets, Total 0.566
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 153.34 143.451 118.577 102.135 171.079
Cash and Short Term Investments 127.716 102.523 82.269 65.921 140.825
Cash & Equivalents 127.716 102.523 82.269 65.921 140.825
Total Receivables, Net 17.881 20.9 20.399 21.166 16.325
Accounts Receivable - Trade, Net 4.285 4.923 2.52 6.895 0.703
Prepaid Expenses 7.743 20.028 15.909 14.482 13.374
Total Assets 169.941 166.156 142.172 126.045 195.711
Property/Plant/Equipment, Total - Net 13.103 19.517 20.935 22.115 22.413
Other Long Term Assets, Total 3.498 3.188 2.66 1.795 2.219
Total Current Liabilities 20.116 33.876 26.638 27.654 31.228
Accounts Payable 8.053 10.865 10.1 8.762 6.708
Accrued Expenses 5.432 15.857 10.238 9.598 9.607
Notes Payable/Short Term Debt 0 0 0 0 3.375
Current Port. of LT Debt/Capital Leases 0.141 2.812 2.867 2.813 0
Other Current Liabilities, Total 6.49 4.342 3.433 6.481 11.538
Total Liabilities 29.886 40.222 34.086 36.453 47.782
Total Long Term Debt 4.857 2.327 2.374 2.219 1.766
Long Term Debt 4.557 2.127 2.174 2.219 1.766
Capital Lease Obligations 0.3 0.2 0.2 0
Other Liabilities, Total 4.913 4.019 5.074 6.58 14.788
Total Equity 140.055 125.934 108.086 89.592 147.929
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 0.003 0.003 0.003 0.003 0.005
Additional Paid-In Capital 310.934 313.673 315.394 317.135 393.925
Retained Earnings (Accumulated Deficit) -164.339 -181.492 -201.532 -222.766 -240.734
Other Equity, Total -6.543 -6.25 -5.779 -4.78 -5.267
Total Liabilities & Shareholders’ Equity 169.941 166.156 142.172 126.045 195.711
Total Common Shares Outstanding 29.8144 29.8716 29.9038 31.2032 54.6925
Property/Plant/Equipment, Total - Gross 25.351 27.176 28.481 29.044
Accumulated Depreciation, Total -5.834 -6.241 -6.366 -6.631
Other Current Assets, Total 0.566 0.555
  • Annual
  • Quarterly
2017 2018 2019 2020 2021
Net income/Starting Line -12.723 -16.237 -43.037 -44.082 -75.665
Cash From Operating Activities -11.913 -14.998 -41.731 -39.339 -66.016
Cash From Operating Activities 0.398 0.64 1.443 4.15 4.64
Non-Cash Items 0.725 0.874 7.241 8.71 8.87
Cash Taxes Paid 0.004 0.024 0 0 0.001
Cash Interest Paid 0.06 0.071 0.064 0.097 0.048
Changes in Working Capital -0.313 -0.275 -7.378 -8.117 -3.861
Cash From Investing Activities -1.297 -2.15 -1.999 -2.371 -12.581
Capital Expenditures -1.297 -2.15 -1.999 -2.371 -12.581
Cash From Financing Activities 58.892 6.873 109.751 73.42 -0.235
Issuance (Retirement) of Stock, Net 58.892 6.864 112.03 75.063 0.203
Issuance (Retirement) of Debt, Net 0 0.009 -2.279 -1.419 -0.438
Foreign Exchange Effects 2.494 -2.507 -1.026 -2.108 2.567
Net Change in Cash 48.176 -12.782 64.995 29.602 -76.265
Financing Cash Flow Items -0.224 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -17.238 -34.391 -54.43 -75.665 -17.968
Cash From Operating Activities -14.397 -35.129 -52.773 -66.016 1.733
Cash From Operating Activities 1.103 2.321 3.412 4.64 1.078
Non-Cash Items 1.521 4.181 5.901 8.87 1.695
Cash Taxes Paid 0 0 0.001 0.001 0
Cash Interest Paid 0 0.024 0.024 0.048 0
Changes in Working Capital 0.217 -7.24 -7.656 -3.861 16.928
Cash From Investing Activities -0.33 -4.954 -7.44 -12.581 -1.828
Capital Expenditures -0.33 -4.954 -7.44 -12.581 -1.828
Cash From Financing Activities 0.101 0.186 0.175 -0.235 75.293
Issuance (Retirement) of Stock, Net 0.125 0.237 0.239 0.203 75.313
Issuance (Retirement) of Debt, Net -0.024 -0.051 -0.064 -0.438 -0.02
Foreign Exchange Effects -0.406 -0.327 -0.442 2.567 -0.307
Net Change in Cash -15.032 -40.224 -60.48 -76.265 74.891
Financing Cash Flow Items 0 0 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Deep Track Capital LP Hedge Fund 9.6259 5035998 0 2022-09-30 MED
Fidelity Management & Research Company LLC Investment Advisor 9.6252 5035645 -638566 2022-09-30 LOW
EcoR1 Capital, LLC Hedge Fund 9.5571 5000000 0 2022-09-30 MED
Redmile Group, LLC Investment Advisor/Hedge Fund 8.7204 4562248 0 2022-09-30 LOW
Gilead Sciences Inc Corporation 7.1859 3759465 1666666 2022-02-15 LOW
Sofinnova Partners Venture Capital 6.0075 3142956 360 2022-04-13 LOW
Baker Bros. Advisors LP Hedge Fund 4.5883 2400481 0 2022-09-30 LOW
Invus Public Equities Advisors, LLC Investment Advisor 3.5354 1849616 0 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.371 1763621 111890 2022-09-30 LOW
Forbion Capital Partners Venture Capital 1.7737 927966 -1213921 2021-12-31 LOW
BofA Global Research (US) Research Firm 0.8569 448296 -2997 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7509 392825 0 2022-09-30 LOW
Millennium Management LLC Hedge Fund 0.7303 382095 -320643 2022-09-30 HIGH
RBC Capital Markets Wealth Management Research Firm 0.5558 290756 28263 2022-09-30 LOW
Takeda Pharmaceutical Co Ltd Corporation 0.5556 290693 -1042895 2021-07-22 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.492 257423 3437 2022-09-30 LOW
EQT Life Sciences Venture Capital 0.4143 216776 26704 2021-06-30 LOW
Bridgeway Capital Management, LLC Investment Advisor 0.3838 200800 123500 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3339 174690 565 2022-09-30 LOW
Renaissance Technologies LLC Hedge Fund 0.2718 142200 47500 2022-09-30 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+485000+

Trader

65000+

Klien aktif per bulan

$48000000+

Volume investasi per bulan

$28000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Pharmaceuticals (NEC)

430 East 29Th Street
14Th Floor
NEW YORK
NEW YORK 10016-8367
US

Income Statement

  • Annual
  • Quarterly

People also watch

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Biaya inap posisi Long -0.1138%
Biaya inap posisi short 0.0796%
Waktu biaya inap 22:00 (UTC)
Spread 0.005

XRP/USD

0.41 Price
+0.060% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 0.00279

BTC/USD

23,396.25 Price
-0.090% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 60.00

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Biaya inap posisi Long -0.0223%
Biaya inap posisi short 0.0065%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda